Editeur commercial ElsevierInternational audienceThe present study evaluates Error Dynamics Shaping (EDS) as an alternative closed-loop strategy for subcutaneous insulin delivery in type 1 diabetes. EDS uses the energy-based principle of damping to ensure a robust stability of closed-loop systems despite strong unknown disturbances. It benefits from intuitive tuning criteria and provides explicit state feedback control laws requiring few computational resources. Using FDA approved UVa T1DM simulator, the robustness of an EDS controller against meal profile variability was tested in one scenario over a day and three scenarios over a week with meal variability. No hypoglycaemia was recorded and hyperglycaemias kept limited. In silico, EDS con...
Arguably, a minimally invasive system using subcutaneous (s.c.) continuous glucose monitoring (CGM) ...
The development of a closed-loop artificial pancreas to regulate the blood glucose concentration of ...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
Editeur commercial ElsevierInternational audienceThe present study evaluates Error Dynamics Shaping ...
International audienceThe present study evaluates Error Dynamics Shaping (EDS) as an alternative clo...
The present study evaluates Error Dynamics Shaping (EDS) as an alternative closed-loop strategy to c...
A closed-loop insulin delivery requires a control algorithm particularly robust to meal-induced dist...
The artificial pancreas aims at the automatic delivery of insulin for glycemic control in patients w...
In order for an "artificial pancreas" to become a reality for ambulatory use, a practical closed-loo...
The objective of this work is to automatically regulate glycemia of Type 1 Diabetes Mellitus (T1DM) ...
Maintaining good glycemic control is a continuous challenge for type-1 diabetic patients. The curren...
This paper examines the performance of two new closed-loop control strategies developed as part of t...
The artificial pancreas (AP) is a system intended to control blood glucose levels through automated ...
Background: Artificial pancreas design using subcutaneous insulin infusion without pre-meal feed-for...
Arguably, a minimally invasive system using subcutaneous (s.c.) continuous glucose monitoring (CGM) ...
The development of a closed-loop artificial pancreas to regulate the blood glucose concentration of ...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
Editeur commercial ElsevierInternational audienceThe present study evaluates Error Dynamics Shaping ...
International audienceThe present study evaluates Error Dynamics Shaping (EDS) as an alternative clo...
The present study evaluates Error Dynamics Shaping (EDS) as an alternative closed-loop strategy to c...
A closed-loop insulin delivery requires a control algorithm particularly robust to meal-induced dist...
The artificial pancreas aims at the automatic delivery of insulin for glycemic control in patients w...
In order for an "artificial pancreas" to become a reality for ambulatory use, a practical closed-loo...
The objective of this work is to automatically regulate glycemia of Type 1 Diabetes Mellitus (T1DM) ...
Maintaining good glycemic control is a continuous challenge for type-1 diabetic patients. The curren...
This paper examines the performance of two new closed-loop control strategies developed as part of t...
The artificial pancreas (AP) is a system intended to control blood glucose levels through automated ...
Background: Artificial pancreas design using subcutaneous insulin infusion without pre-meal feed-for...
Arguably, a minimally invasive system using subcutaneous (s.c.) continuous glucose monitoring (CGM) ...
The development of a closed-loop artificial pancreas to regulate the blood glucose concentration of ...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...